Abstract
Objective
To assess the clinical efficacy of global traditional Chinese medicine (TCM) therapy in treating senile advanced non-small cell lung cancer (NSCLC), with the aim of seeking a standardized, rational and economical way to treat advanced NSCLC in old patients.
Methods
A retrospective analysis and comparison was carried out in 86 patients with senile advanced NSCLC, 44 treated by global TCM (TCM group) and 42 by chemotherapy (control group) through dynamical observation on related indexes including tumor size, quality of life and the survival time, as well as on the fee for medical service at various time points in the course of the treatment.
Results
The changes of tumor size, score of clinical main symptoms and behavior condition (by ZPS scoring), as well as survival rates in the two groups at corresponding time points, were not different significantly (P>0.05). The mean survival time in the TCM group was 13.20±1.52 months and that in the chemotherapy group was 13.45±1.94 months, showing insignificant difference between them. However, the median survival time in the TCM group (12 months) was actually longer than that in the chemotherapy group (9 months, P<0.05). The mean daily expense and the mean expense (RMB yuan) for each patient in the TCM group were significantly lower than that in the control group, which was 180.73±93.21 vs 825.84±329.63 for the mean daily expense and 34 077.21±14 638.04 vs 58 516.59±45 429.76 for the mean expense for each patient (both P<0.01).
Conclusion
Treatment of senile advanced NSCLC with TCM alone has its apparent superiority in stabilizing tumor focus, improving clinical symptoms, elevating quality of life and prolonging the survival time. TCM is also less expensive, making it a good alternative therapeutic approach for this specific group of people.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chinese Medicine Association. Guide of clinical diagnosis and treament. Volume of Oncology. Beijing: People’s Medical Publishing House, 2005:106–107, 129–130.
Chu DT, ed. Evaluation on contemporary oncology Internal therapy regimen. Beijing: Peking Medical University Press, 1998:153–165.
Sun Y, ed. Oncology of internal medicine. Beijing: People’ s Medical Publishing House, 2000:996–997.
Chen KJ, ed. Lung Cancer. Beijing: China Medico-Pharmaceutical Sciences and Technology Publishing House, 2000:3–4.
Xu ZY, Yang YF, eds. Integrated traditional Chinese and Western therapy of lung cancer. People’s Medical Publishing House, 2002:7–8.
Gu YQ. Epidemiology and therapy characteristics of senile oncology. Geriatr Health Care (Chin) 2002;8(2):74–76.
Wu YL, ed. Theory and practice of multi-subject combination therapy on lung cancer. Beijing: People’ s Medical Publishing House, 2000:7–8.
Ricci S, Antonuzzo A, Galli L, et al. Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study. Lung Cancer 2000;27:75–80.
Hainsworth JD, Burris HA 3rd, Litchy S, et al. Weekly docetaxel in the treatment of elderly pantients with advanced non-small cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial. Cancer 2000;89:328–330.
The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of winorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999;91:66–72.
Frasci G, Comella P, Panza N, et al. Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients Gruppo Oncologico Cooperativo Sud-Italia. Eur J Cancer 1998;34:1710–1714.
Medical Politics Office, P. R. China. Standardization of diagnosis and treatment of malignant tumor-Primary bronchogenic carcinoma of lung. 2nd ed. Beijing: People’s Medical Publishing House, 1991:3–4.
Luo J, Chu DT. Evaluation of the role of quality of life in treatment of malignant tumor with traditional Chinese medicine. Chin J Oncol (Chin) 2002;24(4):41–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, Jh., Liu, Ws., Li, Zm. et al. A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer. Chin. J. Integr. Med. 13, 269–274 (2007). https://doi.org/10.1007/s11655-007-0269-4
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11655-007-0269-4